tiprankstipranks
Trending News
More News >
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
Japanese Market

JCR Pharmaceuticals Co., Ltd. (4552) Income Statement

Compare
1 Followers

JCR Pharmaceuticals Co., Ltd. Income Statement

Last quarter (Q3 2025), JCR Pharmaceuticals Co., Ltd.'s total revenue was ¥9.22B, a decrease of -2.36% from the same quarter last year. In Q3, JCR Pharmaceuticals Co., Ltd.'s net income was ¥115.00M. See JCR Pharmaceuticals Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 42.87B¥ 34.34B¥ 51.08B¥ 30.09B¥ 24.78B
Gross Profit
¥ 31.25B¥ 25.46B¥ 40.62B¥ 22.27B¥ 16.88B
Operating Expenses
¥ 23.72B¥ 20.48B¥ 20.69B¥ 14.00B¥ 13.63B
Depreciation and Amortization
¥ 3.20B¥ 2.00B¥ 1.95B¥ 1.89B¥ 1.43B
EBITDA
¥ 10.53B¥ 6.97B¥ 21.88B¥ 10.18B¥ 4.68B
Operating Income
¥ 7.53B¥ 4.97B¥ 19.93B¥ 8.27B¥ 3.24B
Other Income/Expenses
¥ -288.00M¥ 437.00M¥ -529.00M¥ 384.00M¥ 178.00M
Pretax Income
¥ 7.24B¥ 5.41B¥ 19.40B¥ 8.65B¥ 3.42B
Net Income
¥ 5.51B¥ 3.77B¥ 14.51B¥ 6.89B¥ 2.68B
Per Share Metrics
Basic EPS
¥ 44.13¥ 30.34¥ 117.26¥ 55.80¥ 21.72
Diluted EPS
¥ 43.92¥ 30.22¥ 116.79¥ 55.52¥ 21.59
Weighted Average Shares Outstanding
124.79M 124.31M 123.72M 123.52M 123.28M
Weighted Average Shares Outstanding (Diluted)
125.40M 124.84M 124.21M 124.13M 124.04M
Currency in JPY

JCR Pharmaceuticals Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis